This bill mandates that, starting January 1, 2027, every individual or group health insurance contract, plan, or policy that provides prescription coverage and is delivered, issued for delivery, prescribed, or renewed in Rhode Island must include coverage for at least one type of glucagon auto-injector, nasal spray, or formulation that does not require reconstitution. The legislation specifies that there shall be no copayment or deductible required to obtain two glucagon auto-injectors, nasal spray, or non-reconstituted formulations covered by the contract, plan, or policy, every twelve-month plan year. A deductible may be applied to health plans that are paired with federally qualified health savings accounts pursuant to 26 U.S.C. 223. The bill also allows for the implementation of this benefit prior to January 1, 2027. The act amends several chapters of the General Laws related to accident and sickness insurance policies, nonprofit hospital service corporations, nonprofit medical service corporations, and health maintenance organizations to incorporate this new requirement. The act is set to take effect upon passage.